Back to top
more

Bruker Corporation (BRKR)

(Delayed Data from NSDQ)

$41.47 USD

41.47
1,285,436

+1.51 (3.78%)

Updated Aug 16, 2019 03:58 PM ET

Add to portfolio

3-Hold     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.80%
17.93%
9.58%
5.18%
2.03%
10.63%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

D Value | B Growth | B Momentum | C VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Zacks Equity Research

Bruker (BRKR) Q2 Earnings Beat Estimates, Margins Expand

Bruker (BRKR) registers strong year-over-year revenue growth across all segments and geographies.

BRKR ISRG SYK BAX

Zacks Equity Research

Bruker (BRKR) Beats Q2 Earnings and Revenue Estimates

Bruker (BRKR) delivered earnings and revenue surprises of 6.45% and 2.71%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

BRKR

Zacks Equity Research

Garmin's (GRMN) Q2 Earnings & Revenues Surpass Estimates

Garmin's (GRMN) second-quarter results benefit from strong performance by its fitness, outdoor, marine and aviation segments.

DATA RST GRMN BRKR

Zacks Equity Research

Can Bruker (BRKR) Q2 Earnings See BioSpin's Growth Revival?

Bruker (BRKR) expects BioSpin to bode well for better organic growth in Q2.

BRKR TECH AVXL HSIC

Zacks Equity Research

Is Bruker (BRKR) Outperforming Other Computer and Technology Stocks This Year?

Is (BRKR) Outperforming Other Computer and Technology Stocks This Year?

BRKR

Zacks Equity Research

Bruker (BRKR) Earnings Expected to Grow: Should You Buy?

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BRKR

Zacks Equity Research

Illumina (ILMN) Grows on Innovation & International Growth

Illumina (ILMN) is benefiting from sturdy demand for sequencing and array systems as well as consumables and services.

TFX BRKR PEN ILMN

Zacks Equity Research

NuVasive (NUVA) Launches Pulse Integrated Technology Platform

The launch of this system is in sync with NuVasive's (NUVA) endeavor to deliver end-to-end solutions that offer predictable clinical and economic outcomes in spine surgery.

TFX BRKR PEN NUVA

Zacks Equity Research

Boston Scientific's Global Growth Robust Amid Currency Woe

Boston Scientific (BSX) is currently pinning hopes on a stronger performance in China, backed by the recent approval of SYNERGY in the country.

TFX BRKR PEN BSX

Zacks Equity Research

Has Bruker (BRKR) Outpaced Other Computer and Technology Stocks This Year?

Is (BRKR) Outperforming Other Computer and Technology Stocks This Year?

BRKR

Zacks Equity Research

Medtronic Releases Positive Results of LATERAL Clinical Trial

Positive outcomes prove to be a major breakthrough for Medtronic (MDT) in the growing field of ventricular assist devices.

TFX BRKR PEN MDT

Zacks Equity Research

ResMed (RMD) Rides on Strong SaaS Growth & New Product Suite

ResMed's (RMD) new product menu and an array of strategies are likely to benefit from the sleep-disordered breathing market. This should further drive its short-term performance.

TFX BRKR PEN RMD

Zacks Equity Research

Integra Partners AI-Driven Data Analytics Firm in Wound Care

Integra LifeSciences (IART) expects its partnership with Tissue Analytics to be perfectly strategic as the latter's software solutions automatically derive high quality data from clinical pictures.

TFX BRKR PEN IART

Zacks Equity Research

Phibro Animal Sees Crucial Progress in ASF Vaccine Development

The identification of a group of peptides and proteins is a remarkable step toward Phibro's (PAHC) development of a solution for ASF.

PAHC TFX BRKR PEN

Zacks Equity Research

Fresenius Set for Global Expansion of Research Activities

Fresenius Medical Care (FMS) aims to expand the scope of its clinical research activities through an integration move.

TFX BRKR FMS PEN

Zacks Equity Research

Illumina (ILMN) Hits 52-Week High, Can the Run Continue?

Illumina (ILMN) gains from expansion of its product portfolio and strategic partnership.

TFX BRKR PEN ILMN

Zacks Equity Research

CVS Health Banks on Aetna Prospects, Omnicare May Disappoint

CVS Health's (CVS) Aetna integration synergies bode well for the stock.

TFX BRKR PEN CVS

Zacks Equity Research

Boston Scientific to Sell Bead Suit, Make Way for BTG Buyout

The sale of oncology bead products by Boston Scientific (BSX) is expected to be among the last steps undertaken by the company to obtain Federal Trade Commission's approval for BTG buyout.

TFX BRKR PEN BSX

Zacks Equity Research

Here's Why CVS Health (CVS) Should Be in Your Portfolio

Investors' trust continues to be high in CVS Health (CVS), thanks to strength in its PBM business.

TFX BRKR PEN CVS

Zacks Equity Research

Here's Why Chemed (CHE) Should Remain in Your Portfolio Now

Investors' trust in Chemed (CHE) continues to be high, banking on its sturdy segmental performance.

TFX BRKR PEN CHE

David Bartosiak

Five Runaway Breakout Stocks to Buy

With the market at all-time highs again, the rich get richer as stocks continue to breakout.

KELYA ILMN CMI CASY BRKR

Zacks Equity Research

Here's Why Bruker (BRKR) is a Great Momentum Stock to Buy

Does Bruker (BRKR) have what it takes to be a top stock pick for momentum investors? Let's find out.

BRKR

Zacks Equity Research

The Zacks Analyst Blog Highlights: Universal Display, Bruker, Match, j2 and Ciena

The Zacks Analyst Blog Highlights: Universal Display, Bruker, Match, j2 and Ciena

MTCH JCOM OLED CIEN BRKR

Swarup Gupta

5 Top Tech Gainers of 1H19

The Technology Select Sector SPDR Fund (XLK) is the leading performer among the S&P 500's 11 sectors year to date.

JCOM MTCH OLED CIEN BRKR NVDA ON MU

Zacks Equity Research

Here's Why You Should Add Bruker (BRKR) to Your Portfolio

Investor confidence in Bruker stock (BRKR) is high on substantial potential of MALDI Biotyper.

BRKR MASI PEN COO